The FDA doesn't seem to be in a rush to buff their tarnished reputation worldwide. Novavax has a SP that has increased in value over the last five years (496.48%) = $248.16 at closing...not in a particular rush either...to run the gauntlet necessary to gain FDA approval/thumbs up. We live in a world...without doubt, driven by profit...rather than brotherly love...a bonus but, not necessarily part of the equation.